Is a complete QNTM research report available?

No complete published report is available for Quantum BioPharma Ltd. (QNTM) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Quantum BioPharma Ltd. (QNTM)

NASDAQ: QNTM · USD

$2.84

+0.01 (+0.3%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first QNTM analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	18.2M
Net income (ttm)	-31.2M
EPS (ttm)	-$8.22
Shares out	6.4M
Volume	48,290
Beta	0.44

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -31.2M
EPS (ttm): -$8.22
Market cap: 18.2M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All QNTM indicators

Market & fundamental data

Available fields

169

Groups with data

Currency

USD

Showing 169 of 169 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001771885
Company name	Quantum BioPharma Ltd.
Country	Canada
Country code	US
Cusip	74764Y205
Employees	17
Employees Change	7%
Employees Change Percent	70
Enterprise value	$12.5M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	CA74764Y2050
Last refreshed	2026-07-31
Market cap	$18.2M
Market cap category	Nano-Cap
Price	$2.84
Price currency	USD
Sector	Healthcare
Sector PE	45.21
Sector PE Fwd	23.64
Sic	2834
Symbol	QNTM
Website	https://www.quantumbiopharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-171.54%
FCF yield	-31.08%

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-31.2M
Net Income Growth Years	0%
Profit Per Employee	$-1.8M
ROA	-62.38
Roa5y	-48.6
ROCE	1,047.3
ROE	-2,056.5
Roe5y	-139.3
ROIC	-353.4

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-87.36%
Cagr3y	-65.77%
Cagr5y	-51.98%
EPS Growth Quarters	4
EPS Growth Years	6
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$14.9M
Cash	$4.6M
Current Assets	$10.4M
Current Liabilities	$16.3M
Debt	$870,057
Equity	$-1.4M
Interest Coverage	-8.25
Liabilities	$16.3M
Long Term Assets	$4.6M
Long Term Liabilities	$0
Net Cash	$3.7M
Net Cash By Market Cap	$20.34
Net Cash Growth	63.56%
Tangible Book Value	$-3.8M
Tangible Book Value Per Share	$-0.65
WACC	13.85

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.63
Net Working Capital	$-9.7M
Quick ratio	0.29
Working Capital	$-6M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-136.38%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-87.35%
200-day SMA	6
3Y total return	-95.99%
50-day SMA	4.25
50-day SMA vs 200-day SMA	50under200
5Y total return	-97.44%
All Time High	11,431.9
All Time High Change	-99.98%
All Time High Date	2018-09-10
All Time Low	2.07
All Time Low Change	37.2%
All Time Low Date	2026-03-11
ATR	0.3
Beta	0.44
Ch YTD	-61.1
High	2.98
High52	31.91
High52 Date	2025-08-11
High52ch	-91.1%
Low	2.83
Low52	2.07
Low52 Date	2026-03-11
Low52ch	37.2%
Ma50ch	-33.24%
Premarket Change Percent	-2.12
Premarket Price	$2.77
Premarket Volume	366
Price vs 200-day SMA	-52.64%
RSI	33.7
RSI Monthly	37.95
RSI Weekly	40.6
Sharpe ratio	-0.77x
Sortino ratio	-1.26
Total Return	-136.38%
Tr YTD	-61.1
Tr1m	-23.24%
Tr3m	-49.73%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Earnings EPS Estimate	$-0.51
Operating Income	$-14.9M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	5,961,457%
Float Percent	93.17%
Net Borrowing	2,368,922
Shares Insiders	6.83%
Shares Institutions	11.55%
Shares Out	6,398,647
Shares Qo Q	17.16%
Shares Yo Y	136.38%
Short Float	5.69%
Short Ratio	2.58
Short Shares	5.3

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-9.2M
Adjusted OCF	-9,191,205
Average Volume	85,138.7x
Bv Per Share	0.1
Ch1m	-23.24
Ch1y	-87.35
Ch3m	-49.73
Ch3y	-95.99
Ch5y	-97.44
Ch6m	-41.68
Change	0.35%
Change From Open	0.35
Close	2.83
Days Gap	0
Depreciation Amortization	543,526
Dollar Volume	137,143.6
Earnings Date	2026-08-05
Earnings Time	bmo
EBIT	$-14.9M
EBITDA	$-14.3M
EPS	$-8.22
F Score	1
FCF	$-5.6M
FCF EV Yield	-45.13x
FCF Per Share	$-0.88
Financing CF	9,964,033
Fiscal Year End	December
Founded	1,998
Investing CF	-3,495,520
Is Primary Listing	0
Is Spac	No
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Last Split Date	2024-08-15
Last Split Type	Reverse
Last10k Filing Date	2026-03-26
Ma150	4.56
Ma150ch	-37.71%
Ma20	3.18
Ma20ch	-10.78%
Net CF	823,595
Next Earnings Date	2026-08-10
Open	2.83
Optionable	No
Position In Range	6.67
Post Close	2.84
Postmarket Change Percent	-1.41
Postmarket Price	$2.8
Ppne	147,537
Pre Close	2.83
Price Date	2026-07-30
Relative Volume	0.58x
Share Based Comp	3,546,287
Tr6m	-41.68%
Volume	48,290

Quantum BioPharma Ltd. (QNTM)

Coverage state: Market snapshot only — no published research

Generate the first QNTM analysis

Price

Financial snapshot

Fair-value bridge

Latest news · QNTM

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All QNTM indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on QNTM

Frequently asked questions